DAFTAR PUSTAKA

1. Arslam M, Bocca S, Mirkin S, Barroso G, Stadtmauer L, Oehninger S. Controlled

ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience
after the birth of Elizabeth Carr. Fertil Steril. 2005;84:555-69.
2. Tinkanen H, Blauer M, Laippala P, Tuohimaa P, Kujansuu E. Prognostic factors in
controlled ovarian hyperstimulation. Fertil Steril. 1999;72:932-6.
3. Allahbadia GN. Manual of Ovulation Induction. Jaypee Brothers Medical Publishers,
New Delhi 2005 : 166-71.
4. Blankstein J, Shalev J, Saadon T, Kukia EE, Rabinovici J, Pariente C, et al, Ovarian
hyperstimulation syndrome : prediction by number and size of preovulatory ovarian
follicles. Fertil Steril 1987; 47: 597-602.
5. McArdle C, Siebel M, Hann LE, Weinstein F, Taymor M. The diagnosis of ovarian
stimulation (OHS) : the impact of ultrasound. Fertil Steril 1983; 39 : 464-7.
6. Pride SM, James CSJ, Yuen BH. The ovarian hyperstimulation syndrome. Semin Reprod
Endocrinol 1990; 8 : 247-60.
7. Speroff L, Glass RH, Kase NG. Female infertility. In: Mitchell C, Reter R, Stewart J,
Magee RD, editors. Clinical gynecologic endocrinology and fertility. 6th ed.
Baltimore:William & Wilkins; 1994.p.1013-42.
8. Palter SF, Olive DL. Reproductive physiology. In: Berek JS, Adashi EY, Hillard PA ed.
Novak’s gynecology 12th ed. Baltimore:William & Wilkins;1996.p.149-74.
9. Ganong WF. Physiology of reproduction in women. In: DeCherney AH, Pernoll ML
editors. Curr obstetric & gynecologic diagnosis & treatment. 8th ed.
Connecticut:Appleton&Lange;1994.p.124-45
10. Baziad A. Endokrinologi ginekologi. Edisi ke 2. Jakarta:Media Aesculapius; 2003.
11. Hornstein MD, Schust D. Infertility. In: Berek JS, Adashi EY, Hillard PA, editors.
Novak’s gynecology 12th ed. Baltimore:William & Wilkins;1996.p.915-62.
12. Bergh PA, Navot D. Ovarian hyperstimulation syndrome : a review of pathophysiology. J
Assisst Reprod Genet 1992; 9 : 429-38.
13. Derkx FH, Alberda AT, Zeilmaker GH, Schalekamp MA. High concentrations of
immunoreactive rennin, prorenin and enzymatically-active rennin in human ovarian
follicular fluid. Br J Obstet Gynecol 1987; 94 : 4-9.
14. Lightman A, Tarlatzis BC, Rzasa PJ, Culler MD, Caride VJ, Negro-Vilar AF, et al. The
ovarian renin-angiotensin system : renin-like- activity and angiotensin II/III
immunoreactivity in gonadotropin-stimulated and unstimulated human follicular fluid.
Am J Obstet Gynecol 1987; 156 : 808-16.
15. Geva E, Jaffe RB. Role of vascular endothelial growth factor in ovarian physiology and
pathology. Fertil Steril 2000; 74 : 429-38.
16. Levin ER, Rosen GF, Cassidenti DL, Yee B, Meldrum D, Wisot A, et al. Role of vascular
endothelial cell growth factor in ovarian hyperstimulation syndrome. J Clin Invest 1998;
102 : 1978-85.

20
17. Neulen J, Yan Z, Raczek S, Weindel K, Keek C, Weich HA, et al. Human chorionic
gonadotropin-dependent expression of vascular endothelial growth factor/vascular
permeability agent in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 1995;
80 : 1967-71.
18. Pellicer A, Albert C, Mercader A, BonillaMusoles F, Remohi J, Simon C. The
pathogenesis of ovarian hyperstimulation syndrome : in vivo studies investigating the
role of interleukin-1 , interleukin-6, and endothelial growth factor. Fertil Steril 1999; 71
: 482-9.
19. Whelan JG 3rd, Vlahos NF. The ovarian hyperstimulation syndrome. Fertil Steril 2000;
73 : 883-96.
20. Navot D, Relou A, Birkenfeld A, Rabinowitz R, Brzezinski A, Margalioth EJ. Risk
factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet
Gynecol 1988; 159 : 210-5.
21. Enskog A, Henriksson M, Unander M, Nilsson L, Brannstrom M. Prospective stury of the
clinical and laboratory parameters of patients in whom ovarian hyperstimulation
syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization.
Fertil Steril 1999; 71 : 808-14
22. Forman RG, Frydman R, Egan D, Ross C, Barlow DH. Severe ovarian hyperstimulation
syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization : a
European series and a proposal for prevention. Fertil Steril 1990; 53 : 502-9.
23. Zosmer A, Katz Z, Lancet M, Konichezky S, Schwartz-Shoham Z. Adult respiratory
distress syndrome complicating ovarian hyperstimulation syndrome. Fertil Steril 1987; 47
: 524-6.
24. Abramov Y, Elchalal U, Schenker JG. Pulmonary manifestation of severe ovarian
hyperstimulation syndrome : a multicenter study. Fertil Steril 1999; 71 : 645-51.
25. Pattinson HA, Hignett M, Dunphy BC, Fleetham JA. Outcome of thaw embryo transfer
after cryopreservation of all embryos in patients at risk of ovarian hyperstimulation
syndrome. Fertil Steril 1994; 62 : 1192-6.
26. Shaker AG, Zosmer A, Dean N, Bekir JS, Jacobs HS, Tan SL. Comparison of
intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos
for subsequent transfer in prevention of ovarian hyperstimulation syndrome [see
comments, Fertil Steril 1997; 67 : 587-9]. Fertil Steril 1996; 65 : 992-6.
27. Ferraretti AP, Gianaroli L, Magli C, Fortini D, Selman HA, Feliciani E. Elective
cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation
syndrome : efficiency and safety. Hum Reprod 1999; 14 : 1457-60.
28. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive
technologies : prevention and treatment. Fertil Steril 1992; 58 : 249-61.
29. Borenstein R, Elhalah U, Lunenfeld B, Schwartz ZA. Severe ovarian hyperstimulation
syndrome : a reevaluated therapeutic approach. Fertil Steril 1989; 51 : 791-5.

21
30. Aboulghar MA, Mansour RT, Serour GI, Amin Y. Ultrasonically guided vaginal
aspiration of ascites in the treatment of severe ovarian hyperstimulation syndrome
[erratum appears in Fertil Steril 1990; 54 : 957]. Fertil Steril 1990; 53 : 933-5.
31. Rizk B, Abloulghar M. Modern management of ovarian hyperstimulation syndrome : a
multicenter study. Hum Reprod 1991; 6 : 1082-7.
32. Rinaldi ML, Spirtos NJ. Chest tube drainage of pleural effusion correcting abnormal
ascites in a patient with severe ovarian hyperstimulation syndrome : a case report
[comment Fertil Steril 1995; 64 : 1228-9]. Fertil Steril 1995; 63 : 1114-7.
33. Ferraretti AP, Gianaroli L, Diotallevi L, Festi C, Trounson A. Dopamine treatment for
severe ovarian hyperstimulation syndrome [comments Hum Reprod 1992; 7 : 1181].
Hum Reprod 1992; 7 : 180-3.
34. Reed Ap, Tausk H, Reynolds H. Anesthetic considerations for severe ovarian
hyperstimulation syndrome. Anesthesiology 1990; 73 : 1275-7.
35. Grochowski D, Wolczynski S, Kuczynski W, Domirtz J, Szamatowitcz J, Szamatowitcz
M. Correctly time coasting reduces the risk of ovarian hyperstimulation syndrome and
gives good cycle outcome in an in vitro fertilization program. Gynecol Endocrinol 2001;
15 : 234-8.
36. Al-Shawaf T, Zosmer A, Hussain S, Tozer A, Panay N, Wilson C et al. Prevention of
severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo
transfer : a modified “coasting” strategy absed on ultraosun for identification of high-risk
patients. Hum Reprod 2001; 16 : 24-30.
37. Ulug U, Bahceci M, Erden HF, Shalev E, Ben-Shlomo I. The significance of coasting
duration during ovarian stimulation for conception in assisted fertilization cycles. Hum
Reprod 2002; 17 : 310-3.
38. Lewit N, Kol S, Manor D, Itskovitz-Eldor J. Comparison of gonadotrophin-releasing
hormone analogues and human chorionic gonadotrophine for the induction of ovulation
and prevention of ovarian hyperstimulation syndrome : a case control study. Hum
Reprod 1996; 11 : 1399-402.
39. Weissmiller DG. The perimenopause and menopause experience. An overwiev. Clin Fam
Prac. 2002; 4 (1): 1-12
40. Speroff L, Glass RH, Kase NG. Menopause and perimenopausal transition. In: Speroff L,
Glass RH, Kase NG eds. Clinical gynecologic endocrinology and infertility. 6th ed.
Philadelphia: Lippincott Williams & Wilkins. 1999; 263-707
41. Rebar RW, De Cherney AH. Assisted reproductive technology in the United States. N
Engl J Med. 2004; 350 (16): 1603-4
42. Pines A, Shapira I, Mijatovic V, Margalioth EJ. The impact of hormonal therapy for
infertility on the age at menopause. Maturitas. 2002; 41: 283-7
43. Chedraui P, Aguirre W, Hidalgo L, Fayad L. Assessing menopausal symptoms among
healthy middle aged women with the Menopause Rating Scale. Maturitas. 2007; 57: 271-
8

22
44. . De Bruin JP, Bovenhuis H, Van Noord PAH. The role of genetic factors in age at
natural menopause. Hum reprod. 2001; 16 (9): 2014-8
45. Van Asselt KM, Kok HS, Pearson PL, Dubas JS, Peeters PHM, Te Velde ER.
Heritability of menopausal age in mothers and daughters. Fertil Steril. 2004: 82; 1348-51
46. De Boer EJ, Tonkelaar ID, te Velde ER, Burger CW, Klip H, van Leewen FE. A low
number of retrieved oocytes at in vitro fertilization treatment is predictive of early
menopause. Fertil steril. 2002; 77: 978-85

23